Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

84 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
CRAFT-A Proposed Framework for Decentralized Clinical Trials Participation in Canada.
Sundquist S, Batist G, Brodeur-Robb K, Dyck K, Eigl BJ, Lee DK, Limoges J, Longstaff H, Pankovich J, Sadura A, Sullivan P, Dancey JE. Sundquist S, et al. Among authors: eigl bj. Curr Oncol. 2021 Sep 30;28(5):3857-3865. doi: 10.3390/curroncol28050329. Curr Oncol. 2021. PMID: 34677247 Free PMC article. Review.
Phase I Dose-Escalation Study of the Safety and Pharmacokinetics of AGS15E Monotherapy in Patients with Metastatic Urothelial Carcinoma.
Petrylak DP, Eigl BJ, George S, Heath EI, Hotte SJ, Chism DD, Nabell LM, Picus J, Cheng SY, Appleman LJ, Sonpavde GP, Morgans AK, Pourhosseini P, Wu R, Standley L, Croitoru R, Yu EY. Petrylak DP, et al. Among authors: eigl bj. Clin Cancer Res. 2024 Jan 5;30(1):63-73. doi: 10.1158/1078-0432.CCR-22-3627. Clin Cancer Res. 2024. PMID: 37861407 Free PMC article. Clinical Trial.
Intra-individual comparison of 18F-sodium fluoride PET-CT and 99mTc bone scintigraphy with SPECT in patients with prostate cancer or breast cancer at high risk for skeletal metastases (MITNEC-A1): a multicentre, phase 3 trial.
Bénard F, Harsini S, Wilson D, Zukotynski K, Abikhzer G, Turcotte E, Cossette M, Metser U, Romsa J, Martin M, Mar C, Saad F, Soucy JP, Eigl BJ, Black P, Krauze A, Burrell S, Nichol A, Tardif JC. Bénard F, et al. Among authors: eigl bj. Lancet Oncol. 2022 Dec;23(12):1499-1507. doi: 10.1016/S1470-2045(22)00642-8. Epub 2022 Nov 4. Lancet Oncol. 2022. PMID: 36343655 Clinical Trial.
Adherence to oral hormonal therapy in advanced prostate cancer: a scoping review.
Fleshner NE, Alibhai SMH, Connelly KA, Martins I, Eigl BJ, Lukka H, Aprikian A. Fleshner NE, et al. Among authors: eigl bj. Ther Adv Med Oncol. 2023 Mar 29;15:17588359231152845. doi: 10.1177/17588359231152845. eCollection 2023. Ther Adv Med Oncol. 2023. PMID: 37007631 Free PMC article. Review.
Canadian Urological Association/Genitourinary Medical Oncologists of Canada consensus statement: Management of unresectable locally advanced and metastatic urothelial carcinoma.
Warren M, Kolinsky M, Canil CM, Czaykowski P, Sridhar SS, Black PC, Booth CM, Kassouf W, Eapen L, Mukherjee SD, Blais N, Eigl BJ, Winquist E, Basappa NS, North SA; GUMOC. Warren M, et al. Among authors: eigl bj. Can Urol Assoc J. 2019 Oct;13(10):318-327. doi: 10.5489/cuaj.6015. Can Urol Assoc J. 2019. PMID: 31059420 Free PMC article. No abstract available.
Optimizing management of advanced urothelial carcinoma: A review of emerging therapies and biomarker-driven patient selection.
Black PC, Alimohamed NS, Berman D, Blais N, Eigl B, Karakiewicz PI, Kassouf W, Kulkarni GS, Ong M, Spatz A, Sridhar SS, Stockley T, van der Kwast T, Hew H, Park-Wyllie L, North SA. Black PC, et al. Can Urol Assoc J. 2020 Aug;14(8):E373-E382. doi: 10.5489/cuaj.6458. Can Urol Assoc J. 2020. PMID: 32209217 Free PMC article. Review.
Editorial Comment.
Soleimani M, Eigl BJ. Soleimani M, et al. Among authors: eigl bj. J Urol. 2021 Mar;205(3):717. doi: 10.1097/JU.0000000000001412.01. Epub 2021 Jan 5. J Urol. 2021. PMID: 33399490 No abstract available.
84 results